on Affluent Medical (isin : FR0013333077)
Carvolix Liquidity Contract Review for the First Half of 2026
On July 8, 2026, Affluent Medical published the half-year report on the Carvolix liquidity contract. Managed by Rothschild Martin Maurel, the liquidity account as of June 30, 2026, held 1,391 shares and €234,326. Between January and June 2026, 1,878 purchases were made, totaling 106,012 shares for €337,294.46. Concurrently, 1,630 sales took place, representing 112,525 shares for €344,721.56.
Compared to the end of 2025, when the account held 11,800 shares and €208,448, a significant decrease in the number of shares is observed. Following a reorganization, Rothschild & Co Global Markets Solutions now manages the contract, without altering the established terms.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Affluent Medical news